The combination of pregnancy-associated biomarkers in maternal peripheral blood and genetic diagnosis (including mutations in genes such as Androgen Receptor, Wilms Tumor 1, and Sex-determining Region Y) may potentially bridge the gap in diagnosing fetal hypospadias during the early and middle stages of pregnancy. The gene discussed is AR; the disease is hypospadias.